Evidence map›Paper›PMID 35179706›Full record

ArticleBrain imaging and behavior2022

Disassociated and concurrent structural and functional abnormalities in the drug-naïve first-episode early onset schizophrenia.

Qiang Li, Sha Liu, Xiaohua Cao, Zexuan Li, Yun-Shuang Fan, Yanfang Wang, Jiaojian Wang, Yong Xu

Open access · hybridAbstract read
In one paragraph

Article in Brain imaging and behavior, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Frontiers in neural circuits · 2024
    Article
  5. Article
  6. Resolving the Delusion Paradox.Schizophrenia bulletin · 2023
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Qiang Li *Shanxi Key Laboratory of Artificial Intelligence Assisted Diagnosis and Treatment for Mental Disorder/Department of Psychiatry, First Hospital of Shanxi Medical University, No. 85 Jiefang Nan Road, Taiyuan, China.
Sha Liu *Shanxi Key Laboratory of Artificial Intelligence Assisted Diagnosis and Treatment for Mental Disorder/Department of Psychiatry, First Hospital of Shanxi Medical University, No. 85 Jiefang Nan Road, Taiyuan, China.
Xiaohua Cao *Shanxi Key Laboratory of Artificial Intelligence Assisted Diagnosis and Treatment for Mental Disorder/Department of Psychiatry, First Hospital of Shanxi Medical University, No. 85 Jiefang Nan Road, Taiyuan, China.
Zexuan LiShanxi Key Laboratory of Artificial Intelligence Assisted Diagnosis and Treatment for Mental Disorder/Department of Psychiatry, First Hospital of Shanxi Medical University, No. 85 Jiefang Nan Road, Taiyuan, China.
Yun-Shuang FanSchool of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu, 625014, China.
Yanfang WangShanxi Key Laboratory of Artificial Intelligence Assisted Diagnosis and Treatment for Mental Disorder/Department of Psychiatry, First Hospital of Shanxi Medical University, No. 85 Jiefang Nan Road, Taiyuan, China.
Jiaojian WangCenter for Language and Brain, Shenzhen Institute of Neuroscience, Shenzhen, 518057, China.
Yong XuShanxi Key Laboratory of Artificial Intelligence Assisted Diagnosis and Treatment for Mental Disorder/Department of Psychiatry, First Hospital of Shanxi Medical University, No. 85 Jiefang Nan Road, Taiyuan, China. xuyongsmu@vip.163.com.ORCID http://orcid.org/0000-0001-9679-2273
Shanxi Medical University · CNShenzhen Institute of Neuroscience · CNUniversity of Electronic Science and Technology of China · CN

Funding

Guangdong key basic research scheme 2018B030332001Guangdong Pearl River Talents Plan 2016ZT06S220the Multidisciplinary Team for Cognitive Impairment of Shanxi Science and Technology Innovation Training Team 201705D131027the National Key Research and Development Program of China 2016YFC1307004the National Natural Science Foundation of China 81701326the National Natural Science Foundation of China 81901360the National Natural Science Foundation of China 81971601
6 · The paper itself

Abstract

Schizophrenia which is an abnormally developmental disease has been widely reported to show abnormal brain structure and function. Enhanced functional integration is a predominant neural marker for brain mature. Abnormal development of structure and functional integration may be a biomarker for early diagnosis of schizophrenia. Fifty-five patients with early onset schizophrenia (EOS) and 79 healthy controls were enrolled in this study. Voxel-based morphometry (VBM) and functional connectivity density (FCD) were performed to explore gray matter volume (GMV) lesion, abnormal functional integration, and concurrent structural and functional abnormalities in the brain. Furthermore, the relationships between abnormalities structural and function and clinical characteristics were evaluated in EOS. Compared with healthy controls, EOS showed significantly decreased GMV in the bilateral OFC, frontal, temporal, occipital, parietal and limbic system. EOS also showed decreased FCD in precuneus and increased FCD in cerebellum. Moreover, we found concurrent changes of structure and function in left lateral orbitofrontal cortex (lOFC). Finally, correlation analyses did not find significant correlation between abnormal neural measurements and clinical characteristic in EOS. The results reveal disassociated and bound structural and functional abnormalities patterns in EOS suggesting structural and functional measurements play different roles in delineating the abnormal patterns of EOS. The concurrent structural and functional changes in lOFC may be a biomarker for early diagnosis of schizophrenia. Our findings will deepen our understanding of the pathophysiological mechanisms in EOS.

Indexed as

SchizophreniaBiomarkersBrainGray MatterHumansMagnetic Resonance ImagingBiomarkersEarly onset schizophreniaFunctional connectivity densityGrey matter volumeLeft lateral orbitofrontal cortex

Identifiers

PMID35179706
PMCPMC9279212
OpenAlexW4213367575

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.